Progress in genetic studies of pain and analgesia

Annual Review of Pharmacology and Toxicology

Volumn 49, Issue , 2009, Pages 97-121

  Lacroix Fralish, Michael L ^a   Mogi, Jeffrey S ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; CANNABINOID; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 2D6; KAPPA OPIATE RECEPTOR; MELANOCORTIN 1 RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NICOTINIC RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL SCN9A;

ANALGESIA; ANALGESIC ACTIVITY; CHEMICAL MUTAGENESIS; DRUG TRANSFORMATION; FAMILIAL HEMIPLEGIC MIGRAINE; GENE FREQUENCY; GENE MUTATION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC VARIABILITY; HERITABILITY; HUMAN; JAW DISEASE; MICROARRAY ANALYSIS; NEUROPATHY; NOCICEPTION; NONHUMAN; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS MAPPING; REVIEW; RNA INTERFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; GENETIC POLYMORPHISM; GENETIC PROCEDURES; GENETICS; PATHOPHYSIOLOGY; PHENOTYPE;

ANALGESIA; ANIMALS; GENETIC TECHNIQUES; HUMANS; PAIN; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 62849108429     PISSN: 03621642     EISSN: 15454304     Source Type: Book Series    
DOI: 10.1146/annurev-pharmtox-061008-103222     Document Type: Review

References (235)

1. IASP Subcommittee on Taxonomy. 1979. Pain terms: a list with definitions and notes on usage. Pain 6:249-52 [Medline]
2. Woolf CJ, Salter MW. 2000. Neuronal plasticity: increasing the gain in pain. Science 288:1765-68 [CrossRef] [Medline] [ISI]
3. Maniadakis N, Gray A. 2000. The economic burden of back pain in the UK. Pain 84:95-103 [CrossRef] [Medline] [ISI]
4. Liebeskind JC. 1991. Pain can kill. Pain 44:3-4 [CrossRef] [Medline] [ISI]
5. Macfarlane GJ, McBeth J, Silman AJ. 2001. Widespread body pain and mortality: prospective population-based study. Br. Med. J. 323:662-64 [CrossRef] [Medline] [ISI]
6. Brune K. 2002. Next generation of everyday analgesics. Am. J. Ther. 9:215-23 [CrossRef] [Medline]
7. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. 2005. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118:289-305 [CrossRef] [Medline] [ISI]
8. Nielsen CS, Price DD, Vassend O, Stubhaug A, Harris JR. 2005. Characterizing individual differences in heat-pain sensitivity. Pain 119:65-74 [CrossRef] [Medline] [ISI]
9. Lanier LH. 1943. Variability in the pain threshold. Science 97:49-50 [CrossRef] [Medline] [ISI]
10. Kim H, Neubert JK, San Miguel A, Xu K, Krishnaraju RK, et al. 2004. Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament. Pain 109:488-96 [CrossRef] [Medline] [ISI]
11. Price DD. 2000. Psychological and neural mechanisms of the affective dimension of pain. Science 288:1769-72 [CrossRef] [Medline] [ISI]
12. Chen ACN, Dworkin SF, Haug J, Gehrig J. 1989. Topographic brain measures of human pain and pain responsivity. Pain 37:129-41 [CrossRef] [Medline] [ISI]
13. Davis KD, Kwan CL, Crawley AP, Mikulis DJ. 1998. Functional MRI study of thalamic and cortical activations evoked by cutaneous heat, cold, and tactile stimuli. J. Neurophysiol. 80:1533-46 [Medline] [ISI]
14. Zubieta J-K, Smith YR, Bueller JA, Xu Y, Kilbourn MR, et al. 2001. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 293:311-15 [CrossRef] [Medline] [ISI]
15. Coghill RC, McHaffie JG, Yen Y-F. 2003. Neural correlates of interindividual differences in the subjective experience of pain. Proc. Natl. Acad. Sci. USA 100:8538-42 [CrossRef] [Medline] [ISI]
16. Veldman PHJM, Reynen HM, Arntz IE, Goris JA. 1993. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet 342:1012-16 [CrossRef] [Medline] [ISI]
17. Andersen G, Vestergaard K, Ingeman-Nielsen M, Jensen TS. 1995. Incidence of central poststroke pain. Pain 61:187-93 [CrossRef] [Medline] [ISI]
18. Cluff RS, Rowbotham MC. 1998. Pain caused by herpes zoster infection. Neurol. Clin. 16:813-32 [CrossRef] [Medline] [ISI]
19. Edwards RR. 2005. Individual differences in endogenous pain modulation as a risk factor for chronic pain. Neurology 65:437-43 [CrossRef] [Medline] [ISI]
20. Aubrun F, Langeron O, Quesnel C, Coriat P, Riou B. 2003. Relationships between measurement of pain using visual analog score and morphine requirements during postoperative intravenous morphine titration. Anesthesiology 98:1415-21 [CrossRef] [Medline] [ISI]
21. Lasagna L, Beecher HK. 1954. The optimal dose of morphine. J. Am. Med. Assoc. 156:230-34 [Medline]
22. Wolff BB, Kantor TG, Jarvik ME, Laska E. 1965. Response of experimental pain to analgesic drugs. I. Morphine, aspirin, and placebo. Clin. Pharmacol. Ther. 7:224-38 [ISI]
23. Levine JD, Gordon NC, Smith R, Fields HL. 1981. Analgesic responses to morphine and placebo in individuals with postoperative pain. Pain 10:379-89 [CrossRef] [Medline] [ISI]
24. Amanzio M, Pollo A, Maggi G, Benedetti F. 2001. Response variability to analgesics: a role for nonspecific activation of endogenous opioids. Pain 90:205-15 [CrossRef] [Medline] [ISI]
25. Day RO, Graham GG, Williams KM, Brooks PM. 1988. Variability in response to NSAIDs: fact or fiction? Drugs 36:643-51 [CrossRef] [Medline] [ISI]
26. Walker JS, Sheather-Reid RB, Carmody JJ, Vial JH, Day RO. 1997. Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 40:1944-54 [CrossRef] [Medline] [ISI]
27. Turk DC, Flor H, Rudy TE. 1987. Pain and families. I. Etiology, maintenance, and psychosocial impact. Pain 30:3-27 [CrossRef] [Medline] [ISI]
28. Bruehl S, Chung OY. 2006. Parental history of chronic pain may be associated with impairments in endogenous opioid analgesic systems. Pain 124:287-94 [CrossRef] [Medline] [ISI]
29. Edwards CL, Fillingim RB, Keefe F. 2001. Race, ethnicity and pain. Pain 94:133-37 [CrossRef] [Medline] [ISI]
30. Campbell CM, France CR, Robinson ME, Logan HL, Geffken GR, Fillingim RB. 2008. Ethnic differences in the nociceptive flexion reflex (NFR). Pain 134:91-96 [CrossRef] [Medline] [ISI]
31. Rahim-Williams FB, Riley JL III, Herrera D, Campbell CM, Hastie BA, Fillingim RB. 2007. Ethnic identity predicts experimental pain sensitivity in African Americans and Hispanics. Pain 129:177-84 [CrossRef] [Medline] [ISI]
32. MacGregor AJ. 2004. The heritability of pain in humans. In The Genetics of Pain, Progress in Pain Research and Management, ed. JS Mogil, pp. 151-70. Seattle: IASP Press
33. Norbury TA, MacGregor AJ, Urwin J, Spector TD, McMahon SB. 2007. Heritability of responses to painful stimuli in women: a classical twin study. Brain 130:3041-49 [CrossRef] [Medline] [ISI]
34. Nielsen CS, Stubhaug A, Price DD, Vassend O, Czajkowski N, Harris JR. 2008. Individual differences in pain sensitivity: genetic and environmental contributions. Pain 136:21-29 [CrossRef] [Medline] [ISI]
35. Battie MC, Videman T, Levalahti E, Gill K, Kaprio J. 2007. Heritability of low back pain and the role of disc degeneration. Pain 131:272-80 [CrossRef] [Medline] [ISI]
36. Arquelles LM, Afari N, Buchwald DS, Clauw DJ, Furner S, Goldberg J. 2006. A twin study of posttraumatic stress disorder symptoms and chronic widespread pain. Pain 124:150-57 [CrossRef] [Medline]
37. Kato K, Sullivan PF, Evengard B, Pedersen NL. 2006. Importance of genetic influences on chronic widespread pain. Arthritis Rheum. 54:1682-86 [CrossRef] [Medline] [ISI]
38. Fejer R, Hartvigsen J, Kyvik KO. 2006. Heritability of neck pain: a population-based study of 33,794 Danish twins. Rheumatology 45:589-94 [CrossRef] [Medline] [ISI]
39. Zondervan KT, Cardon LR, Kennedy SH, Martin NG, Treloar SA. 2005. Multivariate genetic analysis of chronic pelvic pain and associated phenotypes. Behav. Genet. 35:177-88 [CrossRef] [Medline] [ISI]
40. Michalowicz BS, Pihlstrom BL, Hodges JS, Bouchard TJ Jr. 2000. No heritability of temporomandibular joint signs and symptoms. J. Dent. Res. 79:1573-78 [CrossRef] [Medline]
41. MacGregor AJ, Andrew T, Sambrook PN, Spector TD. 2004. Structural, psychological, and genetic influences on low back and neck pain: a study of adult female twins. Arthritis Rheum. 51:160-67 [CrossRef] [Medline]
42. Mogil JS, Wilson SG, Bon K, Lee SE, Chung K, et al. 1999. Heritability of nociception. I. Responses of eleven inbred mouse strains on twelve measures of nociception. Pain 80:67-82 [CrossRef] [Medline] [ISI]
43. Wilson SG, Smith SB, Chesler EJ, Melton KA, Haas JJ, et al. 2003. The heritability of antinociception: common pharmacogenetic mediation of five neurochemically distinct analgesics. J. Pharmacol. Exp. Ther. 304:547-59 [CrossRef] [Medline] [ISI]
44. Wilson SG, Bryant CD, Lariviere WR, Olsen MS, Giles BE, et al. 2003. The heritability of antinociception II: pharmacogenetic mediation of three over-the-counter analgesics in mice. J. Pharmacol. Exp. Ther. 305:755-64 [CrossRef] [Medline] [ISI]
45. Chesler EJ, Ritchie J, Kokayeff A, Lariviere WR, Wilson SG, Mogil JS. 2003. Genotype-dependence of gabapentin and pregabalin sensitivity: the pharmacogenetic mediation of analgesia is specific to the type of pain being inhibited. Pain 106:325-35 [CrossRef] [Medline] [ISI]
46. Elmer GI, Pieper JO, Negus SS, Woods JH. 1998. Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests. Pain 75:129-40 [CrossRef] [Medline] [ISI]
47. Mogil JS, Kest B, Sadowski B, Belknap JK. 1996. Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: influence of nociceptive assay. J. Pharmacol. Exp. Ther. 276:532-44 [Medline] [ISI]
48. Terner JM, Lomas LM, Smith ES, Barrett AC, Picker MJ. 2003. Pharmacogenetic analysis of sex differences in opioid antinociception in rats. Pain 106:381-91 [CrossRef] [Medline] [ISI]
49. Rode F, Thomsen M, Brolos T, Jensen DG, Blackburn-Munro G, Bjerrum OJ. 2007. The importance of genetic background on pain behaviours and pharmacological sensitivity in the rat spared nerve injury model of peripheral neuropathic pain. Eur. J. Pharmacol. 564:103-11 [CrossRef] [Medline] [ISI]
50. Evans WE, Johnson JA. 2001. Pharmacogenomics: the inherited basis for interindividual differences in drug response. Annu. Rev. Genomics Hum. Genet. 2:9-39 [Abstract] [Medline] [ISI]
51. Roses AD. 2000. Pharmacogenetics and the practice of medicine. Nature 405:857-65 [CrossRef] [Medline] [ISI]
52. Wilson SG, Mogil JS. 2001. Measuring pain in the (knockout) mouse: big challenges in a small mammal. Behav. Brain Res. 125:65-73 [CrossRef] [Medline] [ISI]
53. Capecchi MR. 1989. Altering the genome by homologous recombination. Science 244:1288-92 [CrossRef] [Medline] [ISI]
54. Beck JA, Lloyd S, Hafezparast M, Lennon-Pierce M, Eppig JT, et al. 2000. Genealogies of mouse inbred strains. Nat. Genet. 24:23-25 [CrossRef] [Medline] [ISI]
55. Yang H, Bell TA, Churchill GA, Pardo-Manuel de Villena F. 2007. On the subspecific origin of the laboratory mouse. Nature Genet. 39:1100-7 [CrossRef] [Medline] [ISI]
56. Frazer KA, Eskin E, Kang HM, Bogue MA, Hinds DA, et al. 2007. A sequence-based variation map of 8.27 million SNPs in inbred mouse strains. Nature 448:1050-55 [CrossRef] [Medline] [ISI]
57. Panocka I, Marek P, Sadowski B. 1986. Inheritance of stress-induced analgesia in mice. Selective breeding study. Brain Res. 397:152-55 [CrossRef] [Medline] [ISI]
58. Belknap JK, Haltli NR, Goebel DM, Lamé M. 1983. Selective breeding for high and low levels of opiate-induced analgesia in mice. Behav. Genet. 13:383-96 [CrossRef] [Medline] [ISI]
59. Devor M, Raber P. 1990. Heritability of symptoms in an experimental model of neuropathic pain. Pain 42:51-67 [CrossRef] [Medline] [ISI]
60. Mogil JS, Sternberg WF, Marek P, Sadowski B, Belknap JK, Liebeskind JC. 1996. The genetics of pain and pain inhibition. Proc. Natl. Acad. Sci. U.S.A. 93:3048-55 [CrossRef] [Medline] [ISI]
61. Shuster L. 1982. A pharmacogenetic approach to the brain. In Genetics of the Brain, ed. I Lieblich, pp. 157-73. Amsterdam: Elsevier
62. + (GIRK) channels in opioid-induced analgesia. Neurosci. Res. 38:113-16 [CrossRef] [Medline] [ISI]
63. Mogil JS, Ritchie J, Smith SB, Strasburg K, Kaplan L, et al. 2005. Melanocortin-1 receptor gene variants affect pain and m-opioid analgesia in mice and humans. J. Med. Genet. 42:583-87 [CrossRef] [Medline] [ISI]
64. Martinez-Cue C, Baamonde C, Lumbreras MA, Vallina IF, Dierssen M, Florez J. 1999. A murine model for Down syndrome shows reduced responsiveness to pain. Neuroreport 10:1119-22 [Medline] [ISI]
65. Yamazaki K, Nakazawa T, Matsunaga M, Kumazawa A, Kaneko T, Wakabayashi T. 1992. Behavioral study on the gracile axonal dystrophy (GAD) mutant mouse. Exp. Anim. 41:523-27 [ISI]
66. 2+ channel mutant mice, leaner. FEBS Lett. 508:181-86 [CrossRef] [Medline] [ISI]
67. nu/nu and NMRI mice. Pharmacol. Toxicol. 94:59-64 [CrossRef]
68. Ikeda K, Ide S, Han W, Hayashida M, Uhl GR, Sora I. 2005. How individual sensitivity to opiates can be predicted by gene analyses. Trends Pharmacol. Sci. 26:311-17 [CrossRef] [Medline] [ISI]
69. Mogil JS, Yu L, Basbaum AI. 2000. Pain genes?: natural variation and transgenic mutants. Annu. Rev. Neurosci. 23:777-811 [Abstract] [Medline] [ISI]
70. Mogil JS, Grisel JE. 1998. Transgenic studies of pain. Pain 77:107-28 [CrossRef] [Medline] [ISI]
71. Kieffer BL. 1999. Opioids: first lessons from knockout mice. Trends Pharmacol. Sci. 20:19-26 [CrossRef] [Medline] [ISI]
72. Malmberg AB, Zeitz KP. 2004. Studies of pain mechanisms in genetically manipulated mice. In The Genetics of Pain, Progress in Pain Research and Treatment, ed. JS Mogil, pp. 21-48. Seattle: IASP Press
73. LaCroix-Fralish ML, Ledoux JB, Mogil JS. 2007. The Pain Genes Database: an interactive web browser of pain-related transgenic knockout studies. Pain 131:3.e1-3.e4 [CrossRef]
74. Lariviere WR, Chesler EJ, Mogil JS. 2001. Transgenic studies of pain and analgesia: mutation or background phenotype? J. Pharmacol. Exp. Ther. 297:467-73 [Medline] [ISI]
75. Mogil JS, Wilson SG. 1997. Nociceptive and morphine antinociceptive sensitivity of 129 and C57BL/6 inbred mouse strains: implications for transgenic knock-out studies. Eur. J. Pain 1:293-97 [CrossRef] [Medline]
76. Mogil JS, McCarson KE. 2000. Finding pain genes: bottom-up and top-down approaches. J. Pain 1(Suppl. 1):66-80 [CrossRef] [Medline] [ISI]
77. Nolan PM, Peters J, Strivens M, Rogers D, Hagan J, et al. 2000. A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nature 25:440-43
78. Hrabe de Angelis M, Flaswinkel H, Fuchs H, Rathkolb B, Soewarto D, et al. 2000. Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nature 25:444-47
79. Cook MN, Dunning JP, Wiley RG, Chesler EJ, Johnson DK, et al. 2007. Neurobehavioral mutants identified in an ENU-mutagenesis project. Mamm. Genome 18:559-72
80. Sayah DM, Khan AH, Gasperoni TL, Smith SJ. 2000. A genetic screen for novel behavioral mutations in mice. Mol. Psychiat. 5:369-77 [CrossRef] [Medline] [ISI]
81. Ogawa S, Pfaff DW. 1996. Application of antisense DNA method for the study of molecular bases of brain function and behavior. Behav. Genet. 26:279-92 [CrossRef] [Medline] [ISI]
82. Kim DH, Rossi JJ. 2007. Strategies for silencing human disease using RNA interference. Nature Rev. Genet. 8:173-84 [CrossRef] [Medline] [ISI]
83. Rohl T, Kurreck J. 2006. RNA interference in pain research. J. Neurochem. 99:371-80 [CrossRef] [Medline] [ISI]
84. Pasternak GW, Standifer KM. 1995. Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology. Trends Pharmacol. Sci. 16:344-50 [CrossRef] [Medline] [ISI]
85. Anseloni VCZ, He F, Novikova SI, Turnbach Robbins M, Lidow IA, et al. 2005. Alterations in stress-associated behaviors and neurochemical markers in adult rats after neonatal short-lasting local inflammatory insult. Neuroscience 131:635-45 [CrossRef] [Medline] [ISI]
86. Yang H-YT, Mitchell K, Keller JM, Iadarola MJ. 2007. Peripheral inflammation increases Scya2 expression in sensory ganglia and cytokine and endothelial related gene expression in inflamed tissue. J. Neurochem. 103:1628-43 [CrossRef] [Medline] [ISI]
87. Rabert D, Xiao Y, Yiangou Y, Kreder D, Sangameswaran L, et al. 2004. Plasticity of gene expression in injured human dorsal root ganglia revealed by GeneChip oligonucleotide microarrays. J. Clin. Neurosci. 11:289-99 [CrossRef] [Medline] [ISI]
88. Wang X-M, Wu T-X, Hamza M, Ramsay ES, Wahl SM, Dionne RA. 2007. Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain. Pain 128:136-47 [CrossRef] [Medline] [ISI]
89. Wang X-M, Wu T-X, Lee Y-S, Dionne RA. 2006. Rofecoxib regulates the expression of genes related to the matrix metalloproteinase pathway in humans: implication for the adverse effects of cyclooxygenase-2 inhibitors. Clin. Pharmacol. Ther. 79:303-15 [CrossRef] [Medline] [ISI]
90. Chae Y, Park H-J, Hahm D-H, Yi S-H, Lee H. 2006. Individual differences of acupuncture analgesia in humans using cDNA microarray. J. Physiol. Sci. 56:425-31 [CrossRef] [Medline] [ISI]
91. Sjostrand C, Duvefelt K, Steinberg A, Remahl IN, Waldenlind E, Hillert J. 2006. Gene expression profiling in cluster headache: a pilot microarray study. Headache 46:1518-34 [CrossRef] [Medline] [ISI]
92. Garcia-Escudero R, Paramio JM. 2008. Gene expression profiling as a tool for basic analysis and clinical application of human cancer. Mol. Carcinog. 47:573-79 [CrossRef] [Medline] [ISI]
93. Tegeder I, Costigan M, Griffin RS, Abele A, Belfer I, et al. 2006. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nature Med. 12:1269-77 [CrossRef] [Medline] [ISI]
94. Ko J, Na DS, Lee YH, Shin SY, Kim JH, et al. 2002. cDNA microarray analysis of the differential gene expression in the neuropathic pain and electroacupuncture treatment models. J. Biochem. Mol. Biol. 35:420-27 [Medline]
95. Gao YZ, Guo SY, Yin QZ, Hisamitsu T, Jiang XH. 2007. An individual variation study of electroacupuncture analgesia in rats using microarray. Am. J. Chin. Med. 35:767-78 [CrossRef] [Medline] [ISI]
96. McClung CA. 2006. The molecular mechanisms of morphine addiction. Rev. Neurosci. 17:393-402 [Medline] [ISI]
97. Lander ES, Schork NJ. 1994. Genetic dissection of complex traits. Science 265:2037-48 [CrossRef] [Medline] [ISI]
98. Belknap JK, Dubay C, Crabbe JC, Buck KJ. 1996. Mapping quantitative trait loci for behavioral traits in the mouse. In Handbook of Psychiatric Genetics, ed. K Blum, EP Noble, pp. 435-53. New York: CRC Press
99. Paigen K, Eppig JT. 2000. A mouse phenome project. Mamm. Genome 11:715-17 [CrossRef] [Medline] [ISI]
100. Mogil JS. 2004. Complex trait genetics of pain in the laboratory mouse. In The Genetics of Pain, Progress in Pain Research and Management, ed. JS Mogil, pp. 123-49. Seattle: IASP Press
101. Mogil JS. 1999. The genetic mediation of individual differences in sensitivity to pain and its inhibition. Proc. Natl. Acad. Sci. USA 96:7744-51 [CrossRef] [Medline] [ISI]
102. Xu X-J, Wiesenfeld-Hallin Z. 2004. Individual differences in pain: rat models. In The Genetics of Pain, Progress in Pain Research and Management, ed. JS Mogil, pp. 107-21. Seattle: IASP Press
103. Mogil JS, Belknap JK. 1997. Sex and genotype determine the selective activation of neurochemically-distinct mechanisms of swim stress-induced analgesia. Pharmacol. Biochem. Behav. 56:61-66 [CrossRef] [Medline] [ISI]
104. Urca G, Segev S, Sarne Y. 1985. Footshock-induced analgesia: its opioid nature depends on the strain of rat. Brain Res. 329:109-16 [CrossRef] [Medline] [ISI]
105. Rady JJ, Elmer GI, Fujimoto JM. 1999. Opioid receptor selectivity of heroin given intracerebroventricularly differs in six strains of inbred mice. J. Pharmacol. Exp. Ther. 288:438-45 [Medline] [ISI]
106. Lee DH, Chung K, Chung JM. 1997. Strain differences in adrenergic sensitivity of neuropathic pain behaviors in an experimental rat model. Neuroreport 8:3453-56 [Medline] [ISI]
107. Clark FM, Proudfit HK. 1992. Anatomical evidence for genetic differences in the innervation of the rat spinal cord by noradrenergic locus coeruleus neurons. Brain Res. 591:44-53 [CrossRef] [Medline] [ISI]
108. Edwards RR, Haythornthwaite JA, Tella P, Max MB, Raja S. 2006. Basal heat pain thresholds predict opioid analgesia in patients with postherapetic neuralgia. Anesthesiology 104:1243-48 [CrossRef] [Medline] [ISI]
109. Mogil JS, Wilson SG, Bon K, Lee SE, Chung K, et al. 1999. Heritability of nociception. II. "Types" of nociception revealed by genetic correlation analysis. Pain 80:83-93 [CrossRef] [Medline] [ISI]
110. Lariviere WR, Wilson SG, Laughlin TM, Kokayeff A, West EE, et al. 2002. Heritability of nociception. III. Genetic relationships among commonly used assays of nociception and hypersensitivity. Pain 97:75-86 [Medline] [ISI]
111. Shir Y, Zeltser R, Vatine J-J, Carmi G, Belfer I, et al. 2001. Correlation of intact sensibility and neuropathic pain-related behaviors in eight inbred and outbred rat strains and selection lines. Pain 90:75-82 [CrossRef] [Medline] [ISI]
112. Yoon YW, Lee DH, Lee BH, Chung K, Chung JM. 1999. Different strains and substrains of rats show different levels of neuropathic pain behaviors. Exp. Brain Res. 129:167-71 [CrossRef] [Medline] [ISI]
113. Mogil JS, Meirmeister F, Seifert F, Strasburg K, Zimmermann K, et al. 2005. Variable sensitivity to noxious heat is mediated by differential expression of the CGRP gene. Proc. Natl. Acad. Sci. USA 102:12938-43 [CrossRef] [Medline] [ISI]
114. Deleted in proof
115. Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, et al. 2005. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum. Mol. Genet. 14:135-43 [CrossRef] [Medline] [ISI]
116. Lotsch J, Skarke C, Liefhold J, Geisslinger G. 2004. Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives. Clin. Pharmacokinet. 43:983-1013 [CrossRef] [Medline] [ISI]
117. Hamabe W, Maeda T, Kiguchi N, Yamamoto C, Tokuyama S, Kishioka S. 2007. Negative relationship between morphine analgesia and P-glycoprotein expression levels in brain. J. Pharmacol. Sci. 105:353-60 [CrossRef] [Medline] [ISI]
118. Coulbault L, Beaussier M, Verstuyft C, Weickmans H, Dubert L, et al. 2006. Environmental and genetic factors associated with morphine response in the postoperative period. Clin. Pharmacol. Ther. 79:316-24 [CrossRef] [Medline] [ISI]
119. Liang D-Y, Liao G, Lighthall GK, Peltz G, Clark DJ. 2006. Genetic variants of the P-glycoprotein gene Abcb1b modulate opioid-induced hyperalgesia, tolerance and dependence. Pharmacogenet. Genomics 16:825-35 [CrossRef] [Medline] [ISI]
120. Kieffer BL, Gaveriaux-Ruff C. 2002. Exploring the opioid system by gene knockout. Prog. Neurobiol. 66:285-306 [CrossRef] [Medline] [ISI]
121. Belknap JK, Mogil JS, Helms ML, Richards SP, O'Toole LA, et al. 1995. Localization to chromosome 10 of a locus influencing morphine analgesia in crosses derived from C57BL/6 and DBA/2 mouse strains. Life Sci. 57:PL117-24 [CrossRef] [Medline] [ISI]
122. Bergeson SE, Helms ML, O'Toole LA, Jarvis MW, Hain HS, et al. 2001. Quantitative trait loci influencing morphine antinociception in four mapping populations. Mamm. Genome 12:546-53 [CrossRef] [Medline] [ISI]
123. Smith SB, Marker CL, Perry C, Liao G, Sotocinal SG, et al. 2008. Quantitative trait locus and computational mapping identifies Kcnj9 (GIRK3) as a candidate gene affecting analgesia from multiple drug classes. Pharmacogenet. Genomics 18:231-41 [CrossRef] [Medline] [ISI]
124. Grupe A, Germer S, Usuka J, Aud D, Belknap JK, et al. 2001. In silico mapping of complex disease-related traits in mice. Science 292:1915-18 [CrossRef] [Medline] [ISI]
125. Chesler EJ, Rodriguez-Zas SL, Mogil JS. 2001. In silico mapping of mouse quantitative trait loci. Science 294:2423 [CrossRef] [Medline]
126. Darvasi A. 2001. In silico mapping of mouse quantitative trait loci. Science 294:2423 [CrossRef] [Medline]
127. Wang J, Liao G, Usuka J, Peltz G. 2005. Computational genetics: from mouse to human. Trends Genet. 21:526-32 [CrossRef] [Medline] [ISI]
128. Kest B, Wilson SG, Mogil JS. 1999. Sex differences in supraspinal morphine analgesia are dependent on genotype. J. Pharmacol. Exp. Ther. 289:1370-75 [Medline] [ISI]
129. Mogil JS, Wilson SG, Chesler EJ, Rankin AL, Nemmani KVS, et al. 2003. The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans. Proc. Natl. Acad. Sci. USA 100:4867-72 [CrossRef] [Medline] [ISI]
130. Crabbe JC, Wahlsten D, Dudek BC. 1999. Genetics of mouse behavior: interactions with laboratory environment. Science 284:1670-72 [CrossRef] [Medline] [ISI]
131. Chesler EJ, Wilson SG, Lariviere WR, Rodriguez-Zas SL, Mogil JS. 2002. Influences of laboratory environment on behavior. Nature Neurosci. 5:1101-2 [CrossRef] [Medline] [ISI]
132. Chesler EJ, Wilson SG, Lariviere WR, Rodriguez-Zas SL, Mogil JS. 2002. Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive. Neurosci. Biobehav. Rev. 26:907-23 [CrossRef] [Medline] [ISI]
133. Mogil JS, Crager SE. 2004. What should we be measuring in behavioral studies of chronic pain in animals? Pain 112:12-15 [CrossRef] [Medline] [ISI]
134. Vierck CJ, Hansson PT, Yezierski RP. 2008. Clinical and preclinical pain assessment: are we measuring the same thing? Pain 135:7-10 [CrossRef] [Medline] [ISI]
135. Mogil JS, Max MB. 2005. The genetics of pain. In Wall and Melzack's Textbook of Pain, 5th ed., ed. M Koltzenburg, SB McMahon, pp. 159-74. London: Elsevier Churchill Livingstone
136. Diatchenko L, Nackley AG, Tchivileva IE, Shabalina SA, Maixner W. 2007. Genetic architecture of human pain perception. Trends Genet. 23:605-13 [CrossRef] [Medline] [ISI]
137. Lotsch J, Geisslinger G. 2007. Current evidence for a modulation of nociception by human genetic polymorphisms. Pain 132:18-22 [CrossRef] [Medline] [ISI]
138. Limer KL, Nicholl BI, Thomson W, McBeth J. 2008. Exploring the genetic susceptibility of chronic widespread pain: the tender points in genetic association studies. Rheumatology 47:572-77 [CrossRef] [Medline] [ISI]
139. Montagna P. 2007. Recent advances in the pharmacogenomics of pain and headache. Neurol. Sci. 28(Suppl. 2):208-12 [CrossRef]
140. Johnson MP, Fernandez F, Colson NJ, Griffiths LR. 2007. A pharmacogenomic evaluation of migraine therapy. Expert Opin. Pharmacother. 8:1821-35 [CrossRef] [Medline] [ISI]
141. Lotsch J, Geisslinger G. 2006. Current evidence for a genetic modulation of the response to analgesics. Pain 121:1-5 [CrossRef] [Medline] [ISI]
142. Stamer UM, Stuber F. 2007. Genetic factors in pain and its treatment. Curr. Opin. Anaesthesiol. 20:478-84 [CrossRef] [Medline]
143. Caraco Y, Maroz Y, Davidson E. 2001. Variability in alfentanil analgesia may be attributed to polymorphism in the mu opioid receptor. Clin. Pharmacol. Ther. 69:P63 [ISI]
144. Rakvag TT, Klepstad P, Baar C, Kvam T-M, Dale O, et al. 2005. The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain 116:73-78 [CrossRef] [Medline] [ISI]
145. Lee Y-S, Kim H, Wu T-X, Wang X-M, Dionne RA. 2006. Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs. Clin. Pharmacol. Ther. 79:407-18 [CrossRef] [Medline] [ISI]
146. Cox JJ, Reimann F, Nicholas AK, Thornton G, Roberts E, et al. 2006. An SCN9A channelopathy causes congenital inability to experience pain. Nature 444:894-98 [CrossRef] [Medline] [ISI]
147. v1.7 gene underlie congenital indifference to pain in multiple human populations. Clin. Genet. 71:311-19 [CrossRef] [Medline] [ISI]
148. Yang Y, Wang Y, Li S, Xu Z, Li H, et al. 2004. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J. Med. Genet. 41:171-74 [CrossRef] [Medline] [ISI]
149. Fertleman CR, Baker MD, Parker KA, Moffatt S, Elmslie FV, et al. 2006. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 52:767-74 [CrossRef] [Medline] [ISI]
150. Liveing E. 1873. On Megrim, Sick-Headache, and Some Allied Disorders; a Contribution to the Pathology of Nerve-Storms. London: Churchill Press. 512 pp.
151. Peroutka SJ, Wilhoit TL, Boatwright M, Derksen M, Jones KW. 1997. Polymorphisms within the CACNL1A4 gene are not associated with migraine wihout aura or migraine with aura. Headache 37:326-27
152. Lea RA, Curtain RP, Hutchins C, Brimage PJ, Griffiths LR. 2001. Investigation of the CACNA1A gene as a candidate for typical migraine susceptibility. Am. J. Med. Genet. 105:707-12 [CrossRef] [Medline]
153. Risch NJ. 2000. Searching for genetic determinants in the new millennium. Nature 405:847-56 [CrossRef] [Medline] [ISI]
154. Diatchenko L, Nackley AG, Slade GD, Fillingim RB, Maixner W. 2006. Idiopathic pain disorders - pathways of vulnerability. Pain 123:226-30 [CrossRef] [Medline] [ISI]
155. Offenbaecher M, Bondy B, de Jonge S, Glatzeder K, Kruger M, et al. 1999. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum. 42:2482-88 [CrossRef] [Medline] [ISI]
156. Cohen H, Buskila D, Neumann L, Ebstein RP. 2002. Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5-HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Arthritis Rheum. 46:845-47 [CrossRef] [Medline] [ISI]
157. Kim H, Lee H, Rowan J, Brahim J, Dionne RA. 2006. Genetic polymorphisms in monoamine neurotransmitter systems show only weak association with acute postsurgical pain in humans. Mol. Pain 2:24 [CrossRef] [Medline]
158. Jeremias J, Ledger WJ, Witkin SS. 2000. Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis. Am. J. Obstet. Gynecol. 182:283-85 [CrossRef] [Medline] [ISI]
159. Foster DC, Sazenski TM, Stodgell CJ. 2004. Impact of genetic variation in interleukin-1 receptor antagonist and melanocortin-1 receptor genes on vulvar vestibulitis syndrome. J. Reprod. Med. 49:503-9 [Medline] [ISI]
160. Liem EB, Joiner TV, Tsueda K, Sessler DI. 2005. Increased sensitivity to thermal pain and reduced subcutaneous lidocaine efficacy in redheads. Anesthesiology 102:509-14 [CrossRef] [Medline] [ISI]
161. Valverde P, Healy E, Jackson I, Rees JL, Thody AJ. 1995. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nature Genet. 11:328-30 [CrossRef] [Medline] [ISI]
162. 158met genotype affects μ -opioid neurotransmitter responses to a pain stressor. Science 299:1240-43 [CrossRef] [Medline] [ISI]
163. Diatchenko L, Nackley AG, Slade GD, Bhalang K, Belfer I, et al. 2006. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 125:216-24 [CrossRef] [Medline] [ISI]
164. Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, et al. 2006. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314:1930-33 [CrossRef] [Medline] [ISI]
165. Birklein F, Depmeier C, Rolke R, Hansen C, Rautenstrauss B, et al. 2008. A family-based investigation of cold pain tolerance. Pain 138:111-18 [CrossRef] [Medline] [ISI]
166. Kim H, Dionne RA. 2007. Comment on Diatchenko et al. Catechol-O- methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 129:365-66 [CrossRef] [Medline] [ISI]
167. Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B, Erdal N. 2003. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol. Int. 23:104-7 [Medline] [ISI]
168. Armero P, Muriel C, Santos J, Sanchez-Montero FJ, Rodriguez RE, Gonzalez-Sarmiento R. 2005. COMT (Val158Met) polymorphism is not associated to neuropathic pain in a Spanish population. Eur. J. Pain 9:229-32 [CrossRef] [Medline] [ISI]
169. Reyes-Gibby CC, Shete S, Rakvag T, Bhat SV, Skorpen F, et al. 2007. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain 130:25-30 [CrossRef] [Medline]
170. Tegeder I, Adolph J, Schmidt H, Woolf CJ, Geisslinger G, Lotsch J. 2008. Reduced hyperalgesia in homozygous carriers of a GTP cyclohydrolase 1 haplotype. Eur. J. Pain 12:1069-77 [CrossRef] [Medline] [ISI]
171. Kim H, Dionne RA. 2007. Lack of influence of GTP cyclohydrolase gene (GCH1) variations on pain sensitivity in humans. Mol. Pain 3:6 [CrossRef] [Medline]
172. Smith BH, Macfarlane GJ, Torrance N. 2007. Epidemiology of chronic pain, from the laboratory to the bus stop: time to add understanding of biological mechanisms to the study of risk factors in population-based research? Pain 127:5-10 [CrossRef] [Medline] [ISI]
173. NCI-NHGRI Working Group on Replication in Association Studies, Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, et al. 2007. Replicating genotype-phenotype associations. Nature 447:655-60 [CrossRef] [Medline]
174. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. 2002. A comprehensive review of genetic association studies. Genet. Med. 4:45-61 [Medline] [ISI]
175. Campbell CD, Ogburn EL, Lunetta KL, Lyon HN, Freedman ML, et al. 2005. Demonstrating stratification in a European American population. Nat. Genet. 37:868-72 [CrossRef] [Medline] [ISI]
176. Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, et al. 2004. Assessing the impact of population stratification on genetic association studies. Nat. Genet. 36:388-93 [CrossRef] [Medline] [ISI]
177. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. 2003. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nature Genet. 33:177-82 [CrossRef] [Medline] [ISI]
178. Schulze TG, McMahon FJ. 2004. Defining the phenotype in human genetic studies: forward genetics and reverse phenotyping. Hum. Hered. 58:131-38 [CrossRef] [Medline] [ISI]
179. Ioannidis JP. 2005. Why most published research findings are false. PLOS Med. 2:e124 [CrossRef] [Medline]
180. International HapMap Consortium. 2003. The International HapMap Project. Nature 426:789-96 [CrossRef] [Medline] [ISI]
181. Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. 2004. Mapping complex disease loci in whole-genome association studies. Nature 429:446-52 [CrossRef] [Medline] [ISI]
182. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, et al. 2008. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nature Rev. Genet. 9:356-69 [CrossRef] [Medline] [ISI]
183. Belfer I, Wu T, Kingman A, Krishnaraju RK, Goldman D, Max MB. 2004. Candidate gene studies of human pain mechanisms: a method for optimizing choice of polymorphisms and sample size. Anesthesiology 100:1562-72 [CrossRef] [Medline] [ISI]
184. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, et al. 2008. Meta-analysis of genome-wide association data and large-scale replication identifies several additional susceptibility loci for type 2 diabetes. Nature Genet. 40:638-45 [CrossRef] [Medline] [ISI]
185. Furuse T, Miura Y, Yagasaki K, Shiroishi T, Koide T. 2003. Identification of QTLs for differential capsaicin sensitivity between mouse strains KJR and C57BL/6. Pain 105:169-75 [CrossRef] [Medline] [ISI]
186. Wilson SG, Chesler EJ, Hain HS, Rankin AL, Schwarz JZ, et al. 2002. Identification of quantitative trait loci for chemical/inflammatory nociception in mice. Pain 96:385-91 [CrossRef] [Medline] [ISI]
187. 2-opioid receptors. Pain 70:267-77 [CrossRef] [Medline] [ISI]
188. Seltzer Z, Wu T, Max MB, Diehl SR. 2001. Mapping a gene for neuropathic pain-related behavior following peripheral neurectomy in the mouse. Pain 93:101-6 [CrossRef] [Medline] [ISI]
189. Devor M, Gilad A, Arbilly M, Yakir B, Raber P, et al. 2005. Pain1: a neuropathic pain QTL on mouse chromosome 15 in a C3HxC58 backcross. Pain 116:289-93 [CrossRef] [Medline] [ISI]
190. Devor M, Gilad A, Arbilly M, Nissenbaum J, Yakir B, et al. 2007. Sex-specific variability and a 'cage effect' independently mask a neuropathic pain quantitative trait locus detected in a whole genome scan. Eur. J. Neurosci. 26:681-88 [CrossRef] [Medline] [ISI]
191. Nissenbaum J, Shpigler H, Pisante A, delCanho S, Minert A, et al. 2008. Pain 2: a neuropathic pain QTL identified on rat chromosome 2. Pain 135:92-97 [CrossRef] [Medline] [ISI]
192. Hain HS, Belknap JK, Mogil JS. 1999. Pharmacogenetic evidence for the involvement of 5-hydroxytryptamine (serotonin)-1B receptors in the mediation of morphine antinociceptive sensitivity. J. Pharmacol. Exp. Ther. 291:444-49 [Medline] [ISI]
193. Mogil JS, Richards SP, O'Toole LA, Helms ML, Mitchell SR, et al. 1997. Identification of a sex-specific quantitative trait locus mediating nonopioid stress-induced analgesia in female mice. J. Neurosci. 17:7995-8002 [Medline] [ISI]
194. Liang D-Y, Liao G, Wang J, Usuka J, Guo Y, et al. 2006. A genetic analysis of opioid-induced hyperalgesia in mice. Anesthesiology 104:1054-62 [CrossRef] [Medline] [ISI]
195. 2+ channel gene CACNL1A4. Cell 87:543-52 [CrossRef] [Medline] [ISI]
196. + pump a2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet. 33:192-96 [CrossRef] [Medline]
197. Dichgans M, Freilinger T, Eckstein G, Babini E, Lorenz-Depiereux B, et al. 2005. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366:371-77 [CrossRef] [Medline] [ISI]
198. Booth DR, Gillmore JD, Lachmann HJ, Booth SE, Bybee A, et al. 2000. The genetic basis of autosomal dominant familial Mediterranean fever. Quart. J. Med. 93:217-21
199. Kuhlenbaumer G, Hannibal MC, Nelis E, Schirmacher A, Verpoorten N, et al. 2000. Mutations in SEPT9 cause hereditary neuralgic amyotrophy. Nature Genet. 37:1044-46 [CrossRef]
200. Bejaoui K, Wu C, Scheffler MD, Haan G, Ashby P, et al. 2001. SPTLC1 is mutated in hereditary sensory neuropathy, type 1. Nat. Genet. 27:261-62 [CrossRef] [Medline] [ISI]
201. Dawkins JL, Hulme DJ, Brahmbhatt SB, Auer-Grumbach MN, Nicholson GA. 2001. Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat. Genet. 27:309-12 [CrossRef] [Medline] [ISI]
202. Lafreniere RG, MacDonald MLE, Dube M-P, MacFarlane J, O'Driscoll M, et al. 2004. Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy Type II through the study of Canadian genetic isolates. Am. J. Hum. Genet. 74:1064-73 [CrossRef] [Medline] [ISI]
203. Slaugenhaupt SA, Blumenfeld A, Gill SP, Leyne M, Mull J, et al. 2001. Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am. J. Hum. Genet. 68:598-605 [CrossRef] [Medline] [ISI]
204. Anderson SL, Coli R, Daly IW, Kichula EA, Rork MJ, et al. 2001. Familial dysautonomia is caused by mutations of the IKAP gene. Am. J. Hum. Genet. 68:753-78 [CrossRef] [Medline] [ISI]
205. Indo Y, Tsurata Y, Karim MA, Ohta K, Kawano T, et al. 1996. Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. Nature Genet. 13:485-88 [CrossRef] [Medline] [ISI]
206. Einarsdottir E, Carlsson A, Minde J, Toolanen G, Svensson O, et al. 2004. A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception. Hum. Mol. Genet. 13:799-805 [CrossRef] [Medline] [ISI]
207. Park JS, Zhang SY, Jo SH, Seo JB, Li L, et al. 2006. Common adrenergic receptor polymorphisms as novel risk factors for vasospastic angina. Am. Heart J. 151:864-69 [CrossRef] [Medline] [ISI]
208. Ogimoto A, Shigematsu Y, Nakura J, Hara Y, Ohtsuka T, et al. 2005. Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) in patients with coexistent hypertrophic cardiomyopathy and coronary spastic angina. J. Mol. Med. 83:619-25 [CrossRef] [Medline] [ISI]
209. Kang S-C, Lee D-G, Choi J-H, Kim ST, Kim Y-K, Ahn H-J. 2007. Association between estrogen receptor polymorphism and pain susceptibility in female temporomandibular joint osteoarthritis patients. Int. J. Oral Maxillofac. Surg. 36:391-94 [CrossRef] [Medline] [ISI]
210. Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, et al. 2005. Cytokine genotypes correlate with pain and radiologically defined joint damage in patients with juvenile rheumatoid arthritis. Rheumatology 44:1115-21 [CrossRef] [Medline] [ISI]
211. Solovieva S, Leino-Arjas P, Saarela J, Luoma K, Raininko R, Riihimaki H. 2004. Possible association of interleukin 1 gene locus polymorphisms with low back pain. Pain 109:8-19 [CrossRef] [Medline] [ISI]
212. Noponen-Hietala N, Virtanen I, Karttunen R, Schwenke S, Jakkula E, et al. 2005. Genetic variations in IL6 associate with intervertebral disc disease characterized by sciatica. Pain 114:186-94 [CrossRef] [Medline] [ISI]
213. Guimaraes AL, de Sa AR, Victoria JM, de Fatima Correia-Silva J, Gomez MV, Gomez RS. 2006. Interleukin-1b and serotonin transporter gene polymorphisms in burning mouth syndrome patients. J. Pain 7:654-58 [CrossRef] [Medline] [ISI]
214. Kim H, Mittal DP, Iadarola MJ, Dionne RA. 2006. Genetic predictors for acute experimental cold and heat pain sensitivity in humans. J. Med. Genet. 43:e40 [CrossRef] [Medline]
215. Fillingim RB, Ness TJ, Glover TL, Campbell CM, Hastie BA, et al. 2005. Morphine responses and experimental pain: sex differences in side effects and cardiovascular responses but not analgesia. J. Pain 6:116-24 [CrossRef] [Medline] [ISI]
216. Lotsch J, Stuck B, Hummel T. 2006. The human mu-opioid receptor gene polymorphism 118A
217. Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, et al. 1999. The T102C polymorphism of the 5-HT2A-receptor gene in fibromyalgia. Neurobiol. Dis. 6:433-39 [CrossRef] [Medline] [ISI]
218. Pinessi L, Rainero I, Rivoiro C, Rubino E, Gallone S. 2005. Genetics of cluster headache: an update. J. Headache Pain 6:234-36 [CrossRef] [Medline]
219. Gonsalkorale WM, Perrey C, Pravica V, Whorwell PJ, Hutchinson IV. 2003. Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut 52:91-93 [CrossRef] [Medline] [ISI]
220. Pata C, Erdal E, Yazici K, Camdeviren H, Ozkaya M, Ulu O. 2004. Association of the -1438 G/A and 102 T/C polymorphism of the 5-Ht2A receptor gene with irritable bowel syndrome 5-Ht2A gene polymorphism in irritable bowel syndrome. J. Clin. Gastroenterol. 38:561-66 [CrossRef] [Medline] [ISI]
221. Camilleri M, Atanasova E, Carlson PJ, Ahmad U, Kim HJ, et al. 2002. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology 123:425-32 [CrossRef] [Medline] [ISI]
222. van der Veek PP, van den Berg M, de Kroon YE, Verspaget HW, Masclee AA. 2005. Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome. Am. J. Gastroenterol. 100:2510-16 [CrossRef] [Medline] [ISI]
223. Stamer UM, Lehnen K, Hothker F, Bayerer B, Wolf S, et al. 2003. Impact of CYP2D6 genotype on postoperative tramadol analgesia. Pain 105:231-38 [CrossRef] [Medline] [ISI]
224. Gasche Y, Daali Y, Fathi M, Chiappe A, Cottini S, et al. 2004. Codeine intoxication associated with ultrarapid CYP2D6 metabolism. N. Engl. J. Med. 351:2827-31 [CrossRef] [Medline] [ISI]
225. Dalen P, Frengell C, Dahl ML, Sjoqvist F. 1997. Quick onset of severe abdominal pain after codeine in an ultrarapid metabolizer of debrisoquine. Ther. Drug Monit. 19:543-44 [CrossRef] [Medline] [ISI]
226. Romberg RR, Olofsen E, Bijl H, Taschner PE, Teppema LJ, et al. 2005. Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response. Anesthesiology 102:522-30 [CrossRef] [Medline] [ISI]
227. Oertel BG, Schmidt R, Schneider A, Geisslinger G, Lötsch J. 2006. The mu-opioid receptor gene polymorphism 118A>G depletes alfentanil induced analgesia and protects against respiratory depression in homozygous carriers. Pharmacogenet. Genom. 16:625-36 [CrossRef] [Medline] [ISI]
228. Skarke C, Darimont J, Schmidt H, Geisslinger G, Lotsch J. 2003. Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers. Clin. Pharmacol. Ther. 73:107-21 [CrossRef] [Medline] [ISI]
229. Lötsch J, Skarke C, Grösch S, Darimont J, Schmidt H, Geisslinger G. 2002. The polymorphism A118G of the human mu-opioid receptor gene decreases the clinical activity of morphine-6-glucuronide but not that of morphine. Pharmacogenetics 12:3-9 [CrossRef] [Medline]
230. Janicki PK, Schuler G, Francis D, Bohr A, Gordin V, et al. 2006. A genetic association study of the functional A118G polymorphism of the human μ-opioid receptor gene in patients with acute and chronic pain. Anesth. Analg. 103:1011-17 [CrossRef] [Medline] [ISI]
231. Shoskes DA, Albakri Q, Thomas K, Cook D. 2002. Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response. J. Urol. 168:331-35 [CrossRef] [Medline] [ISI]
232. Sery O, Hrazdilova O, Didden W, Klenerova V, Staif R, et al. 2006. The association of monoamine oxidase B functional polymorphism with postoperative pain intensity. Neuroendocrinol. Lett. 27:333-37 [Medline] [ISI]
233. 2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. Am J. Med. Genet. 141B:449-62 [CrossRef] [ISI]
234. Herken H, Erdal E, Mutlu N, Barlas O, Cataloluk O, et al. 2001. Possible association of temporomandibular joint pain and dysfunction with a polymorphism in the serotonin transporter gene. Am. J. Orthod. Dentofacial Orthop. 120:308-13 [CrossRef] [Medline] [ISI]
235. Gerber S, Bongiovanni AM, Ledger WJ, Witkin SS. 2003. Interleukin-1b gene polymorphism in women with vulvar vestibulitis syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 107:74-77 [CrossRef] [Medline] [ISI]